Insights

Gathering insights about Decipher…

Similar companies to Decipher

Decipher Tech Stack

Decipher uses 8 technology products and services including Gravatar, Font Awesome, jQuery Migrate, and more. Explore Decipher's tech stack below.

Gravatar
Audio, Video, Graphics
Font Awesome
Font Scripts
jQuery Migrate
Javascript Libraries
Modernizr
Javascript Libraries
jQuery
Javascript Libraries
YouTube
Video Players
HTTP/3
Web & Portal Technology
Twitter
Widgets

Media & News

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. The results were presented by Ionis Pharmaceuticals.
Dec 06, 2025 | www.businesswire.com
Deciphera Announces the Opening of a New Office in Zug, Switzerland
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company's growth in Europe and partner markets. The occasion will be commemorated with a ceremony attended by company management, including the CEO of Ono, Gyo Sagara, President and CEO of Deciphera, Ryota Udagawa, and regional government officials,.
Nov 17, 2025 | www.businesswire.com
Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that data from multiple pipeline programs, including long-term and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option, will be presented during the CTOS Annual Meeting 2025, taking place November 12-15 in Boca Raton, Florida. “We are excited.
Nov 12, 2025 | www.businesswire.com
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. “These long-term.
Oct 18, 2025 | www.businesswire.com
Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable m.
Sep 17, 2025 | www.businesswire.com
Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines, and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of vimseltinib for the treatment of.
Jul 28, 2025 | www.businesswire.com
U.S. FDA Grants Full Approval of Deciphera's ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. The FDA previously granted Fast Track designation and Priority Re.
Feb 14, 2025 | www.businesswire.com

Decipher's Email Address Formats

Decipher uses at least 1 format(s):

Decipher Email Formats	Example	Percentage
First.Last@decipher.co.uk	John.Doe@decipher.co.uk	50%
First.Last@decipher.co.uk	John.Doe@decipher.co.uk	50%

Frequently Asked Questions

What is Decipher's phone number?

You can contact Decipher's main corporate office by phone at

+1-207-225-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Decipher's stock symbol?

Decipher is a publicly traded company; the company's stock symbol is DCPH.

What is Decipher's official website and social media links?

Decipher's official website is decipher.co.uk and has social profiles on LinkedIn.

What is Decipher's NAICS code?

Decipher's NAICS code is 54191 - Marketing Research and Public Opinion Polling.

How many employees does Decipher have currently?

As of December 2025, Decipher has approximately 25 employees across 2 continents, including EuropeAsia. Key team members include Md And Founder: N. W.Finance Director: L. N.. Explore Decipher's employee directory with LeadIQ.

What industry does Decipher belong to?

Decipher operates in the Market Research industry.

What technology does Decipher use?

Decipher's tech stack includes GravatarFont AwesomejQuery MigrateModernizrjQueryYouTubeHTTP/3Twitter.

What is Decipher's email format?

Decipher's email format typically follows the pattern of First.Last@decipher.co.uk. Find more Decipher email formats with LeadIQ.

When was Decipher founded?

Decipher was founded in 1997.

Decipher

Q: What is Decipher's official website and social media links?

Decipher's official website is decipher.co.uk. Decipher has social profiles on LinkedIn.

Q: How many employees does Decipher have currently?

Decipher has approximately 25 employees.

Q: What technology does Decipher use?

Decipher's tech stack includes MySQL, LiteSpeed, Google Fonts API, Apache, WordPress.

Market ResearchEngland, United Kingdom11-50 Employees

Decipher is a media strategy and research consultancy that specialises in emerging consumer media.  We operate in the area where consumer technology and consumer media consumption converges, helping major industry players chart the changing business opportunities presented.  We offer a combination of strategic advisory consultancy, consumer research and executive education and are based out of the unique iBurbia Studios media labs in Chiswick.

Company Overview

Phone number: +1-207-225-****
Website: decipher.co.uk
Stock Symbol: DCPH
NAICS Code: 54191 - Marketing Research and Public Opinion Polling
Founded: 1997
Employees: 11-50

Media & News

Funding & Financials

$1M
Decipher's revenue is estimated to be in the range of $1M

Funding & Financials

$1M
Decipher's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Decipher

SurveyMonkey

InMoment

Qualtrics

QuestionPro

Confirmit

Medallia

Typeform

Decipher Tech Stack

Media & News

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Deciphera Announces the Opening of a New Office in Zug, Switzerland

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

U.S. FDA Grants Full Approval of Deciphera's ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

Decipher's Email Address Formats

Frequently Asked Questions

What is Decipher's phone number?

What is Decipher's stock symbol?

What is Decipher's official website and social media links?

What is Decipher's NAICS code?

How many employees does Decipher have currently?

What industry does Decipher belong to?

What technology does Decipher use?

What is Decipher's email format?

When was Decipher founded?

Decipher

Company Overview

Media & News

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Deciphera Announces the Opening of a New Office in Zug, Switzerland

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?